Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
612.75B
Market cap612.75B
Price-Earnings ratio
29.89
Price-Earnings ratio29.89
Dividend yield
2.03%
Dividend yield2.03%
Average volume
10.65M
Average volume10.65M
High today
$259.88
High today$259.88
Low today
$253.17
Low today$253.17
Open price
$259.09
Open price$259.09
Volume
4.02M
Volume4.02M
52 Week high
$259.88
52 Week high$259.88
52 Week low
$151.52
52 Week low$151.52

Stock Snapshot

As of today, Johnson & Johnson(JNJ) shares are valued at $254.55. The company's market cap stands at 612.75B, with a P/E ratio of 29.89 and a dividend yield of 2.03%.

On 2026-06-30, Johnson & Johnson(JNJ) stock traded between a low of $253.17 and a high of $259.88. Shares are currently priced at $254.55, which is +0.5% above the low and -2.1% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 4.02M, against a daily average of 10.65M.

During the past year, Johnson & Johnson(JNJ) stock moved between $151.52 at its lowest and $259.88 at its peak.

During the past year, Johnson & Johnson(JNJ) stock moved between $151.52 at its lowest and $259.88 at its peak.

JNJ News

Nasdaq 37m
If a Stock Market Crash Is Coming, History Shows This Stock Will Be a Brilliant Buy

Key Points This company tends to outperform the market during recessions. It has a highly resilient and reliable business and a rock-solid balance sheet. The...

If a Stock Market Crash Is Coming, History Shows This Stock Will Be a Brilliant Buy
Investor's Business Daily 1h
Dow Jones Medical Giant J&J Breaks Out; PNC, Iron Mountain, Fortinet In Or Near Buy Zones - Investor's Business Daily

...

Dow Jones Medical Giant J&J Breaks Out; PNC, Iron Mountain, Fortinet In Or Near Buy Zones - Investor's Business Daily
Nasdaq 4h
Dow Analyst Moves: JNJ

The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Johnson & Johnso...

Dow Analyst Moves: JNJ

Analyst ratings

69%

of 26 ratings
Buy
69.2%
Hold
26.9%
Sell
3.8%

More JNJ News

Nasdaq 4h
Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick

A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #8 broker pick, on average, out of the 30 stocks ma...

Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick
24/7 Wall St. 5h
Take Home an Electrician's Paycheck Without the High Voltage

Take Home an Electrician’s Paycheck Without the High Voltage By Drew Wood Published Jun 30, 10:38AM EDT Quick Read Replacing a $65,000 electrician salary with...

Take Home an Electrician's Paycheck Without the High Voltage
Simply Wall St 10h
Johnson & Johnson Could Be 31% Below Fair Value After Cancer Drug Progress

Johnson & Johnson (JNJ) is back in focus after the European Medicines Agency’s committee backed expanded use of its cancer drug Tecvayli with Darzalex, alongsid...

Johnson & Johnson Could Be 31% Below Fair Value After Cancer Drug Progress
24/7 Wall St. 2d
Why Today's Retirees May Need More Stocks Than Their Parents Did

Why Today’s Retirees May Need More Stocks Than Their Parents Did By Drew Wood Published Jun 28, 7:11AM EDT Quick Read Modern retirements stretch 25 to 35 year...

Why Today's Retirees May Need More Stocks Than Their Parents Did
Simply Wall St 3d
Johnson & Johnson Stock After 71% One-Year Rally And Pharma Pipeline Focus

If you are wondering whether Johnson & Johnson stock still offers value after a strong run, this article breaks down what the current price might be implying ab...

Johnson & Johnson Stock After 71% One-Year Rally And Pharma Pipeline Focus
Nasdaq 4d
Why Johnson & Johnson Stock Popped on Friday

Key Points Guggenheim analyst Vamil Divan raised his price target on Johnson & Johnson stock today. Upside is perhaps only 12% over the next year, however. 1...

Why Johnson & Johnson Stock Popped on Friday
TipRanks 4d
Johnson & Johnson presents new Imaavy data at EAN 2026 Congress

Johnson & Johnson announced new data across 12 abstracts at the European Academy of Neurology 2026 Congress that offer additional insight into the use of IMAAVY...

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.